Skip to main content
. 2023 Aug 24;13(9):1301. doi: 10.3390/biom13091301

Figure 4.

Figure 4

SAHA treatments in cellular and animal models for neurological disorders. Schematic representation of the tools used. NDDs, neurodevelopmental disorders; AD, Alzheimer’s disease; ASD, autistic spectrum disorders; RTT, Rett syndrome; hiPSs, human-induced pluripotent stem cells; mESs, murine embryonic stem cells; mPNs, murine primary neurons.